{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T15:54:58Z","timestamp":1777650898256,"version":"3.51.4"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2015,7,30]],"date-time":"2015-07-30T00:00:00Z","timestamp":1438214400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2015,7,30]],"date-time":"2015-07-30T00:00:00Z","timestamp":1438214400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P01 CA87969"],"award-info":[{"award-number":["P01 CA87969"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R01 CA49449"],"award-info":[{"award-number":["R01 CA49449"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R01 CA67262"],"award-info":[{"award-number":["R01 CA67262"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Causes Control"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1007\/s10552-015-0640-2","type":"journal-article","created":{"date-parts":[[2015,7,29]],"date-time":"2015-07-29T05:39:30Z","timestamp":1438148370000},"page":"1501-1506","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Urinary melatonin and risk of ovarian cancer"],"prefix":"10.1007","volume":"26","author":[{"given":"Elizabeth M.","family":"Poole","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eva","family":"Schernhammer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leigha","family":"Mills","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan E.","family":"Hankinson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shelley S.","family":"Tworoger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,7,30]]},"reference":[{"key":"640_CR1","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1016\/S1470-2045(07)70373-X","volume":"8","author":"K Straif","year":"2007","unstructured":"Straif K, Baan R, Grosse Y et al (2007) Carcinogenicity of shift-work, painting, and fire-fighting. Lancet Oncol. 8:1065\u20131066","journal-title":"Lancet Oncol."},{"key":"640_CR2","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1158\/1055-9965.EPI-11-0138","volume":"20","author":"EM Poole","year":"2011","unstructured":"Poole EM, Schernhammer ES, Tworoger SS (2011) Rotating night shift work and risk of ovarian cancer. Cancer Epidemiol Biomarkers Prev. 20:934\u2013938","journal-title":"Cancer Epidemiol Biomarkers Prev."},{"key":"640_CR3","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1136\/oemed-2012-101146","volume":"70","author":"P Bhatti","year":"2013","unstructured":"Bhatti P, Cushing-Haugen KL, Wicklund KG, Doherty JA, Rossing MA (2013) Nightshift work and risk of ovarian cancer. Occup Environ Med 70:231\u2013237","journal-title":"Occup Environ Med"},{"key":"640_CR4","doi-asserted-by":"publisher","first-page":"S34","DOI":"10.1016\/j.amepre.2013.10.032","volume":"46","author":"BD Carter","year":"2014","unstructured":"Carter BD, Diver WR, Hildebrand JS, Patel AV, Gapstur SM (2014) Circadian disruption and fatal ovarian cancer. Am J Prev Med 46:S34\u2013S41","journal-title":"Am J Prev Med"},{"key":"640_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.canlet.2008.11.002","volume":"281","author":"AN Viswanathan","year":"2009","unstructured":"Viswanathan AN, Schernhammer ES (2009) Circulating melatonin and the risk of breast and endometrial cancer in women. Cancer Lett 281:1\u20137","journal-title":"Cancer Lett"},{"key":"640_CR6","first-page":"35","volume":"27","author":"VN Anisimov","year":"2006","unstructured":"Anisimov VN (2006) Light pollution, reproductive function and cancer risk. Neuro Endocrinol Lett. 27:35\u201352","journal-title":"Neuro Endocrinol Lett."},{"key":"640_CR7","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.smrv.2012.08.003","volume":"17","author":"EL Haus","year":"2013","unstructured":"Haus EL, Smolensky MH (2013) Shift work and cancer risk: potential mechanistic roles of circadian disruption, light at night, and sleep deprivation. Sleep Med Rev 17:273\u2013284","journal-title":"Sleep Med Rev"},{"key":"640_CR8","first-page":"231","volume":"15","author":"O Treeck","year":"2006","unstructured":"Treeck O, Haldar C, Ortmann O (2006) Antiestrogens modulate MT1 melatonin receptor expression in breast and ovarian cancer cell lines. Oncol Rep 15:231\u2013235","journal-title":"Oncol Rep"},{"key":"640_CR9","doi-asserted-by":"publisher","first-page":"109","DOI":"10.2174\/187221411799015408","volume":"5","author":"V Srinivasan","year":"2011","unstructured":"Srinivasan V, Pandi-Perumal SR, Brzezinski A, Bhatnagar KP, Cardinali DP (2011) Melatonin, immune function and cancer. Recent Pat Endocr Metab Immune Drug Discov. 5:109\u2013123","journal-title":"Recent Pat Endocr Metab Immune Drug Discov."},{"key":"640_CR10","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1006\/gyno.2001.6330","volume":"82","author":"M Futagami","year":"2001","unstructured":"Futagami M, Sato S, Sakamoto T, Yokoyama Y, Saito Y (2001) Effects of melatonin on the proliferation and cis-diamminedichloroplatinum (CDDP) sensitivity of cultured human ovarian cancer cells. Gynecol Oncol 82:544\u2013549","journal-title":"Gynecol Oncol"},{"key":"640_CR11","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1038\/bjc.1989.272","volume":"60","author":"SA Shellard","year":"1989","unstructured":"Shellard SA, Whelan RD, Hill BT (1989) Growth inhibitory and cytotoxic effects of melatonin and its metabolites on human tumour cell lines in vitro. Br J Cancer 60:288\u2013290","journal-title":"Br J Cancer"},{"key":"640_CR12","doi-asserted-by":"publisher","first-page":"2953","DOI":"10.1016\/S0024-3205(00)00882-1","volume":"67","author":"H Bartsch","year":"2000","unstructured":"Bartsch H, Buchberger A, Franz H et al (2000) Effect of melatonin and pineal extracts on human ovarian and mammary tumor cells in a chemosensitivity assay. Life Sci 67:2953\u20132960","journal-title":"Life Sci"},{"key":"640_CR13","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1111\/j.1600-079X.1999.tb00574.x","volume":"26","author":"J Petranka","year":"1999","unstructured":"Petranka J, Baldwin W, Biermann J, Jayadev S, Barrett JC, Murphy E (1999) The oncostatic action of melatonin in an ovarian carcinoma cell line. J Pineal Res 26:129\u2013136","journal-title":"J Pineal Res"},{"key":"640_CR14","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1111\/j.1600-079X.1998.tb00390.x","volume":"25","author":"KT Papazisis","year":"1998","unstructured":"Papazisis KT, Kouretas D, Geromichalos GD et al (1998) Effects of melatonin on proliferation of cancer cell lines. J Pineal Res 25:211\u2013218","journal-title":"J Pineal Res"},{"key":"640_CR15","doi-asserted-by":"publisher","first-page":"e81676","DOI":"10.1371\/journal.pone.0081676","volume":"8","author":"LG Chuffa","year":"2013","unstructured":"Chuffa LG, Fioruci-Fontanelli BA, Mendes LO et al (2013) Characterization of chemically induced ovarian carcinomas in an ethanol-preferring rat model: influence of long-term melatonin treatment. PLoS ONE 8:e81676","journal-title":"PLoS ONE"},{"key":"640_CR16","first-page":"94","volume":"25","author":"CB Moore","year":"2004","unstructured":"Moore CB, Siopes TD (2004) Spontaneous ovarian adenocarcinoma in the domestic turkey breeder hen (Meleagris gallopavo): effects of photoperiod and melatonin. Neuro Endocrinol Lett. 25:94\u2013101","journal-title":"Neuro Endocrinol Lett."},{"key":"640_CR17","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.tox.2006.09.018","volume":"228","author":"I Adriaens","year":"2006","unstructured":"Adriaens I, Jacquet P, Cortvrindt R, Janssen K, Smitz J (2006) Melatonin has dose-dependent effects on folliculogenesis, oocyte maturation capacity and steroidogenesis. Toxicology 228:333\u2013343","journal-title":"Toxicology"},{"key":"640_CR18","first-page":"108","volume":"74","author":"BC Voordouw","year":"1992","unstructured":"Voordouw BC, Euser R, Verdonk RE et al (1992) Melatonin and melatonin\u2013progestin combinations alter pituitary\u2013ovarian function in women and can inhibit ovulation. J Clin Endocrinol Metab 74:108\u2013117","journal-title":"J Clin Endocrinol Metab"},{"key":"640_CR19","first-page":"109","volume":"21","author":"M Karasek","year":"2000","unstructured":"Karasek M, Kowalski AJ, Zylinska K (2000) Serum melatonin circadian profile in women suffering from the genital tract cancers. Neuro Endocrinol Lett. 21:109\u2013113","journal-title":"Neuro Endocrinol Lett."},{"key":"640_CR20","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1093\/jnci\/dji190","volume":"97","author":"ES Schernhammer","year":"2005","unstructured":"Schernhammer ES, Hankinson SE (2005) Urinary melatonin levels and breast cancer risk. J Natl Cancer Inst 97:1084\u20131087","journal-title":"J Natl Cancer Inst"},{"key":"640_CR21","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1080\/00401706.1983.10487848","volume":"25","author":"B Rosner","year":"1983","unstructured":"Rosner B (1983) Percentage points for a generalized ESD many-outlier procedure. Technometrics 25:165\u2013172","journal-title":"Technometrics"},{"key":"640_CR22","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1093\/aje\/kwt302","volume":"179","author":"XS Wang","year":"2014","unstructured":"Wang XS, Tipper S, Appleby PN, Allen NE, Key TJ, Travis RC (2014) First-morning urinary melatonin and breast cancer risk in the Guernsey Study. Am J Epidemiol 179:584\u2013593","journal-title":"Am J Epidemiol"},{"key":"640_CR23","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1093\/aje\/kwu261","volume":"181","author":"SB Brown","year":"2015","unstructured":"Brown SB, Hankinson SE, Eliassen AH et al (2015) Urinary melatonin concentration and the risk of breast cancer in Nurses\u2019 Health Study II. Am J Epidemiol 181:155\u2013162","journal-title":"Am J Epidemiol"},{"key":"640_CR24","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1158\/1055-9965.EPI-08-0637","volume":"18","author":"ES Schernhammer","year":"2009","unstructured":"Schernhammer ES, Hankinson SE (2009) Urinary melatonin levels and postmenopausal breast cancer risk in the Nurses\u2019 Health Study cohort. Cancer Epidemiol Biomarkers Prev. 18:74\u201379","journal-title":"Cancer Epidemiol Biomarkers Prev."},{"key":"640_CR25","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1002\/ijc.21401","volume":"118","author":"S Cos","year":"2006","unstructured":"Cos S, Gonzalez A, Guezmes A et al (2006) Melatonin inhibits the growth of DMBA-induced mammary tumors by decreasing the local biosynthesis of estrogens through the modulation of aromatase activity. Int J Cancer 118:274\u2013278","journal-title":"Int J Cancer"},{"key":"640_CR26","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.ejogrb.2013.11.027","volume":"174","author":"CD Bondi","year":"2014","unstructured":"Bondi CD, Alonso-Gonzalez C, Clafshenkel WP et al (2014) The effect of estradiol, progesterone, and melatonin on estrous cycling and ovarian aromatase expression in intact female mice. Eur J Obstet Gynecol Reprod Biol 174:80\u201385","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"640_CR27","doi-asserted-by":"publisher","first-page":"38294","DOI":"10.1074\/jbc.M403140200","volume":"279","author":"B del Rio","year":"2004","unstructured":"del Rio B, Garcia Pedrero JM, Martinez-Campa C, Zuazua P, Lazo PS, Ramos S (2004) Melatonin, an endogenous-specific inhibitor of estrogen receptor alpha via calmodulin. J Biol Chem 279:38294\u201338302","journal-title":"J Biol Chem"},{"key":"640_CR28","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.ygyno.2013.12.027","volume":"132","author":"A Ciucci","year":"2014","unstructured":"Ciucci A, Zannoni GF, Travaglia D, Petrillo M, Scambia G, Gallo D (2014) Prognostic significance of the estrogen receptor beta (ERbeta) isoforms ERbeta1, ERbeta2, and ERbeta5 in advanced serous ovarian cancer. Gynecol Oncol 132:351\u2013359","journal-title":"Gynecol Oncol"},{"key":"640_CR29","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1158\/1055-9965.936.13.6","volume":"13","author":"ES Schernhammer","year":"2004","unstructured":"Schernhammer ES, Rosner B, Willett WC, Laden F, Colditz GA, Hankinson SE (2004) Epidemiology of urinary melatonin in women and its relation to other hormones and night work. Cancer Epidemiol Biomarkers Prev. 13:936\u2013943","journal-title":"Cancer Epidemiol Biomarkers Prev."}],"container-title":["Cancer Causes & Control"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10552-015-0640-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10552-015-0640-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10552-015-0640-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10552-015-0640-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,12]],"date-time":"2023-08-12T16:22:48Z","timestamp":1691857368000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10552-015-0640-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7,30]]},"references-count":29,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2015,10]]}},"alternative-id":["640"],"URL":"https:\/\/doi.org\/10.1007\/s10552-015-0640-2","relation":{},"ISSN":["0957-5243","1573-7225"],"issn-type":[{"value":"0957-5243","type":"print"},{"value":"1573-7225","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,7,30]]},"assertion":[{"value":"5 June 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"This analysis was approved by the institutional review board of Brigham and Women\u2019s Hospital. Study participants provided informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The authors have no conflicts of interest to disclose.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}